Abstract The discipline of Cardio-Oncology has seen tremendous growth over the past
decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the …

Minority and underresourced communities experience disproportionately high rates of fatal
cancer and cardiovascular disease. The intersection of these disparities within the …

Acetylation is one of the most important methods of modification that lead to a change in the
function of proteins. In humans, metabolic enzymes commonly undergo acetylation, which …

Anthracyclines and trastuzumab are widely used to treat breast cancer but increase the risk
of cardiomyopathy and heart failure. With the use of trastuzumab and anthracycline …

Over the past decade, immunotherapy delivered novel treatments for many cancer types.
However, lung cancer still leads cancer mortality, and non-small-cell lung carcinoma …

Simple Summary Immune checkpoint inhibitors, including monoclonal antibodies directed
against the programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) …

Purpose HER2-targeted therapies are associated with cardiotoxicity which is usually
asymptomatic and reversible. We report the updated cardiac safety assessment of patients …

Abstract The United States has the highest maternal mortality in the developed world with
cardiovascular disease as the leading cause of pregnancy-related deaths. In response to …

Addressing the need for more equitable cardio-oncology care requires attention to existing
disparities in cardio-oncologic disease prevention and outcomes. This is particularly …

Background Developments in medical technology are resulting in continuous decreases in
the cancer mortality rate of patients with gallbladder cancer, while non‐cancer deaths in …